Akari Therapeutics Plc - AKTX
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$1.277M
QoQ value delta ($000)
+$102K
(+8.68%)
Implied price effect (QoQ)
-71.44%
Shares
Total shares
4,452,856
QoQ shares delta
+3,282,789
(+280.56%)
Total shares held by funds (by quarter)
Market chart (AKTX)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
Early Q1 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 787 | 2,723,966 | 0.01% |
| Cresset Asset Management, LLC | 237 | 822,468 | 0.0% |
| Warberg Asset Management LLC | 88 | 308,340 | 0.01% |
| Palo Alto Investors LP | 42 | 146,024 | 0.01% |
| HighTower Advisors, LLC | 22 | 79,236 | 0.0% |
| JANE STREET GROUP, LLC | 20 | 71,644 | 0.0% |
| SmartHarvest Portfolios, LLC | 20 | 69,248 | 0.01% |
| CWA Asset Management Group, LLC | 15 | 55,000 | 0.0% |
| XTX Topco Ltd | 14 | 49,019 | 0.0% |
| UBS Group AG | 9 | 32,855 | 0.0% |
| StoneX Group Inc. | 6 | 21,295 | 0.0% |
| Cerity Partners LLC | 6 | 23,643 | 0.0% |
| Skyview Financial Group LLC | 5 | 20,575 | 0.01% |
| Independent Advisor Alliance | 4 | 17,075 | 0.0% |
| NewEdge Advisors, LLC | 1 | 6,800 | 0.0% |
| Accent Capital Management, LLC | 1 | 5,000 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 0 | 410 | 0.0% |
| MORGAN STANLEY | 0 | 3 | 0.0% |
| Truvestments Capital LLC | 0 | 50 | 0.0% |
| Cornerstone Planning Group LLC | 0 | 5 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 200 | 0.0% |